Filana Therapeutics, Inc. (FLNA)
0.851
-0.01
(-0.77%)
USD |
NASDAQ |
Sep 03, 12:49
Filana Therapeutics Research and Development Expense (Annual) : 26.59M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 26.59M |
| December 31, 2024 | 69.64M |
| December 31, 2023 | 89.42M |
| December 31, 2022 | 68.93M |
| December 31, 2021 | 28.71M |
| December 31, 2020 | 7.292M |
| December 31, 2019 | 6.297M |
| December 31, 2018 | 2.969M |
| December 31, 2017 | 7.615M |
| December 31, 2016 | 9.176M |
| December 31, 2015 | 9.10M |
| December 31, 2014 | 7.306M |
| December 31, 2013 | 4.917M |
| December 31, 2012 | 7.605M |
| Date | Value |
|---|---|
| December 31, 2011 | 8.30M |
| December 31, 2010 | 15.75M |
| December 31, 2009 | 21.06M |
| December 31, 2008 | 45.82M |
| December 31, 2007 | 47.73M |
| December 31, 2006 | 46.80M |
| December 31, 2005 | 32.94M |
| December 31, 2004 | 35.09M |
| December 31, 2003 | 18.91M |
| December 31, 2002 | 11.40M |
| December 31, 2001 | 11.67M |
| December 31, 2000 | 12.60M |
| December 31, 1999 | 2.092M |
| December 31, 1998 | 0.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| CorMedix, Inc. | 19.33M |
| Eloxx Pharmaceuticals, Inc. | 3.056M |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.0042M |
| BioStem Technologies, Inc. | 7.086M |